These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 24826985)

  • 1. Clinically significant hemolytic disease of the newborn secondary to passive transfer of anti-D from maternal RhIG.
    Cohen DN; Johnson MS; Liang WH; McDaniel HL; Young PP
    Transfusion; 2014 Nov; 54(11):2863-6. PubMed ID: 24826985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe hemolytic disease of the newborn caused by anti-Gonzales antibody.
    Leschek E; Pearlman SA; Boudreaux I; Meek R
    Am J Perinatol; 1993 Sep; 10(5):362-4. PubMed ID: 8240594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case Report: First Case of Cefotaxime-Sulbactam-Induced Acute Intravascular Hemolysis in a Newborn With ABO Blood Type Incompatibility by the Mechanism of Non-Immunologic Protein Adsorption.
    Wu Y; Wu Y; Yang Y; Chen B; Li J; Guo G; Xiong F
    Front Immunol; 2021; 12():698541. PubMed ID: 35003054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hemolytic disease of the newborn caused by maternal anti-Di(a): a case report in Taiwan].
    Yung CH; Lin JS; Hu HY; Lyou JY; Chen YR; Chen CR; Hao TC; Peng CS; Tzeng CH
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1995 May; 28(2):146-50. PubMed ID: 9774993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Need to clarify the cause of hemolysis in case report of newborn with clinically significant hemolytic disease and passive transfer of anti-D from maternal RhIG.
    Watchko JF; Triulzi D
    Transfusion; 2014 Nov; 54(11):3017-8. PubMed ID: 25385405
    [No Abstract]   [Full Text] [Related]  

  • 6. A mild case of hemolytic disease of the fetus and newborn due to anti-Sc2.
    Núñez Ahumada MA; Arancibia Aros CE; Villalobos Pavez CE; Pontigo Gonzalez FM; Abarca Arce V; Sandoval Medrano M; Reyes Jorquera S
    Immunohematology; 2021 Sep; 37(3):122-125. PubMed ID: 34591375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-E as a cause of hemolytic disease of the newborn.
    Cheepsattayakorn R; Fongsatitkul L; Chotinaruemol S; Mahawongtong M
    J Med Assoc Thai; 1997 Sep; 80 Suppl 1():S1-4. PubMed ID: 9347637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of pregnancies complicated by anti-E alloimmunization.
    Joy SD; Rossi KQ; Krugh D; O'Shaughnessy RW
    Obstet Gynecol; 2005 Jan; 105(1):24-8. PubMed ID: 15625137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One single dose of 200 microg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy.
    Koelewijn JM; de Haas M; Vrijkotte TG; Bonsel GJ; van der Schoot CE
    Transfusion; 2008 Aug; 48(8):1721-9. PubMed ID: 18507749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A curious case of anti-D antibody titer.
    Hensley JG; Coughlin KP; Klein LL
    J Midwifery Womens Health; 2009; 54(6):497-502. PubMed ID: 19879523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal hemolytic disease due to anti-Diego
    Fu Y; Liu Y; Yang Z; An Y; Su J; Hu S; Luo L
    J Med Case Rep; 2022 Jul; 16(1):274. PubMed ID: 35820960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of Bilirubin According to the Results of the Direct Antiglobulin Test and Its Impact in Hemolytic Disease of the Newborn.
    Shin KH; Lee HJ; Song D; Lee SM; Kim IS; Kim H; Yang EJ; Park KH
    Lab Med; 2019 Apr; 50(2):138-144. PubMed ID: 30192966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemolytic disease of the fetus and newborn caused by an antibody to a low-prevalence antigen, anti-SARA.
    Towns D; Hannon J; Hendry J; Barnes J; Goldman M
    Transfusion; 2011 Sep; 51(9):1977-9. PubMed ID: 21414007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Foetomaternal erythrocyte incompatibilities: from immunohaematologic surveillance of pregnant women to haemolytic disease of the newborn].
    Miquel E; Cavelier B; Bonneau JC; Rouger P
    Transfus Clin Biol; 2005 Feb; 12(1):45-55. PubMed ID: 15814293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cross-sectional study of haemolytic disease of the newborn in Uganda.
    Dhabangi A; Nankunda J; Okaba V; Nakubulwa S; Hume HA; Dzik WH; Heddle NM
    Vox Sang; 2022 Dec; 117(12):1398-1404. PubMed ID: 36342344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemolytic disease of the newborn because of rare anti-Vel.
    van Gammeren AJ; Overbeeke MA; Idema RN; van Beek RH; Ten Kate-Booij MJ; Ermens AA
    Transfus Med; 2008 Jun; 18(3):197-8. PubMed ID: 18598283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of D alloimmunization in pregnancy with plasmapheresis and intravenous immune globulin: case report.
    Fernández Alba JJ; León R; González-Macías C; Paz A; Prado F; Moreno LJ; Torrejón R
    Transfus Apher Sci; 2014 Aug; 51(1):70-2. PubMed ID: 25312036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of hemolytic disease of fetus and newborn despite maternal high-titer IgG anti-Ku.
    Kakaiya RM; Whaley A; Howard-Menk C; Rami J; Papari M; Campbell-Lee S; Malecki Z
    Immunohematology; 2010; 26(3):119-23. PubMed ID: 21214298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Diego a red blood cell alloantibody as a possible cause of anemia in a 3-week-old infant.
    Hundric-Haspl Z; Balen-Marunic S; Tomasic-Susanj E; Tomicic M; Vujaklija-Stipanovic K
    Arch Med Res; 2003; 34(2):149-51. PubMed ID: 12700013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-G in a pregnant patient.
    Cash K; Brown T; Strupp A; Uehlinger J
    Transfusion; 1999 May; 39(5):531-3. PubMed ID: 10336005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.